IMS Solutions is a company developing diagnostic solutions using advanced mass spectrometry and machine learning. Our technology analyses steroid metabolites to identify unique chemical signatures associated with conditions such as adrenocortical cancer, with the aim of allowing faster and more accurate diagnosis. Further product opportunities exist for our data-driven machine learning algorithms in women’s health, particularly in the stratification of patients identified with PMOS (polyendocrine metabolic ovary syndrome) enabling improved management and treatment options for the condition.
IMS Solutions
- Health
- Birmingham, United Kingdom
- £1.1m
- intelligentmassspec.com
- Update Information
More venture news
- 24 Sept 2026

IMS SolutionsIMS Solutions raises a £1.1m seed round led by Midlands Mindforge to develop steroid tests for cancer and PMOS
SeedHealth - 21 Sept 2026

InTouchNowInTouchNow raises a £2.3m seed round led by Ada Ventures to handle inbound patient calls for NHS GP practices
SeedHealth - 21 Sept 2026

SageTech MedicalSageTech Medical secures £2.5m in funding from The FSE Group to capture and recycle waste anaesthetic gases
EquityHealth
